CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (NASDAQ: GENZ) announced today that it has taken steps to strengthen the role of its lead independent director, and appointed new leadership to head the board’s audit committee. These actions, along with the recently announced changes to the senior executive incentive compensation plans, further strengthen the company’s corporate governance.
